Want to join the conversation?
$SNA 2Q15 Q&A: Macgregor of Longbow Research asked about Big Ticket growth. Nick explained that generally big ticket prices are, they have grown actually a double digit the little faster than the Tools Group. I would sa Apples-to-Apples, in terms of pricing, it’s pretty much volume growth in that situation.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.